Literature DB >> 11817584

Matrix metalloproteinases as therapeutic targets in arthritic diseases: bull's-eye or missing the mark?

John A Mengshol1, Kimberlee S Mix, Constance E Brinckerhoff.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11817584     DOI： 10.1002/1529-0131(200201)46:1<13::aid-art497>3.0.co;2-s

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN： 0004-3591


× No keyword cloud information.
  30 in total

1.  In vivo testing of an injectable matrix gel for the treatment of shoulder cuff muscle fatty degeneration.

Authors:  Tai Huynh; John Taehwan Kim; Grady Dunlap; Shahryar Ahmadi; Jeffrey C Wolchok
Journal:  J Shoulder Elbow Surg       Date:  2020-06-09       Impact factor: 3.019

Review 2.  Matrix metalloproteases: underutilized targets for drug delivery.

Authors:  Deepali G Vartak; Richard A Gemeinhart
Journal:  J Drug Target       Date:  2007-01       Impact factor: 5.121

3.  Inhibition of matrix metalloproteinases enhances in vitro repair of the meniscus.

Authors:  Amy L McNulty; J Brice Weinberg; Farshid Guilak
Journal:  Clin Orthop Relat Res       Date:  2008-10-31       Impact factor: 4.176

4.  Chitosan oligosaccharides inhibit IL-1β-induced chondrocyte apoptosis via the P38 MAPK signaling pathway.

Authors:  Chun Zhang; Ling Yu; Yan Zhou; Qi Zhao; Shi-Qing Liu
Journal:  Glycoconj J       Date:  2016-05-13       Impact factor: 2.916

5.  Anti-inflammatory and chondroprotective effects of atorvastatin in a cartilage explant model of osteoarthritis.

Authors:  Nitya N Pathak; Madhu C Lingaraju; Venkanna Balaganur; Vinay Kant; Amar S More; Dhirendra Kumar; Dinesh Kumar; Surendra K Tandan
Journal:  Inflamm Res       Date:  2015-01-18       Impact factor: 4.575

Review 6.  The pathogenic role of angiogenesis in rheumatoid arthritis.

Authors:  Hatem A Elshabrawy; Zhenlong Chen; Michael V Volin; Shalini Ravella; Shanti Virupannavar; Shiva Shahrara
Journal:  Angiogenesis       Date:  2015-07-22       Impact factor: 9.596

7.  Physiological loading of joints prevents cartilage degradation through CITED2.

Authors:  Daniel J Leong; Yong H Li; Xiang I Gu; Li Sun; Zuping Zhou; Philip Nasser; Damien M Laudier; Jameel Iqbal; Robert J Majeska; Mitchell B Schaffler; Mary B Goldring; Luis Cardoso; Mone Zaidi; Hui B Sun
Journal:  FASEB J       Date:  2010-09-08       Impact factor: 5.191

8.  Dual effects of 17beta-oestradiol on interleukin 1beta-induced proteoglycan degradation in chondrocytes.

Authors:  P Richette; M F Dumontier; M François; L Tsagris; C Korwin-Zmijowska; F Rannou; M T Corvol
Journal:  Ann Rheum Dis       Date:  2004-02       Impact factor: 19.103

9.  Inhibitory effect of cyclo-oxygenase-2 inhibitor on the production of matrix metalloproteinases in rheumatoid fibroblast-like synoviocytes.

Authors:  H S Cha; K S Ahn; C H Jeon; J Kim; E M Koh
Journal:  Rheumatol Int       Date:  2003-07-26       Impact factor: 2.631

10.  Overexpression of human matrix metalloproteinase-12 enhances the development of inflammatory arthritis in transgenic rabbits.

Authors:  Xiaofei Wang; Jingyan Liang; Tomonari Koike; Huijun Sun; Tomonaga Ichikawa; Shuji Kitajima; Masatoshi Morimoto; Hisataka Shikama; Teruo Watanabe; Yasuyuki Sasaguri; Jianglin Fan
Journal:  Am J Pathol       Date:  2004-10       Impact factor: 4.307
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.